Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

<table>The multivariate Cox regression analysis for hazard of MACE. Multivariate analysis failed to show a significant decrease in the hazard of MACE with GP IIb/IIIa inhibitor use. In addition to increased patient age, a history of myocardial infarction (MI), diabetes mellitus (DM), and renal disease remained significant predictors of increased hazard of MACE.</table>

BioMed Research International

fig4

Figure 4

Figure 4: Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction 